Chronic Kidney Disease in Disadvantaged Populations

Section 1: Introduction 1. Introduction

Section 2: Burden of Disease: Prevalence of pre-dialysis kidney disease in disadvantaged populations in developed countries 2. Canada 3. Prevalence of pre-dialysis kidney disease in disadvantaged populations in developed countries-United States 4. Chronic kidney disease in China

Section 3: Burden of disease: Prevalence and incidence of pre-dialysis kidney disease in disadvantaged populations in developing countries 5. Integration of Chronic Kidney Disease Prevention into the Uruguayan National Programme for Noncommunicable Diseases 6. Prevalence of chronic kidney disease and associated risk factors in Cuba Section 4: Disparities in ESRD among disadvantaged populations 7. ESRD among indigenous populations in Canada 8. Racial differences in kidney disease and end-stage kidney disease in the USA 9. ESRD in Mexico 10. End stage renal disease in Latin America 11. Kidney Disease in Ethnic Minority Populations in the United Kingdom 12. End-Stage Renal Disease in the Middle East 13. End Stage Renal Disease (ESKD) in Egypt and North Africa 14. End Stage Renal Disease in Sub-Saharan Africa 15. Kidney Disease in South Asia 16. ESRD in South-East Asia 17. Kidney Disease in Maori and Pacific people in New Zealand 18. Kidney Disease among Aboriginal and Torres Strait Islander people in Australia

Section 5: Current view on risk factors 19. Current view on CKD risk factors: Traditional, non-communicable diseases: diabetes, hypertension, and obesity 20. Risk Factors for Kidney Disease in Disadvantaged Populations - Communicable diseases, environmental factors, pollutants 21. Poverty and Renal Disease

Section 6: Unique issues in kidney disease among disadvantaged populations 22. Mesoamerican Nephropathy or Chronic Kidney Disease of Unknown Origin 23. Prematurity, low birthweight and CKD 24. Hypovitaminosis D and Progression of CKD 25. Renal Care in an Unequal

Dr. Garcia-Garcia is the President of the International Federation of Kidney Foundations (IFKF) and Co-Chair of the World Kidney Day Steering Committee; he is the former Chair of the Education Committee and member of the Latin American Dialysis and Kidney Transplantation Registry, both at the Latin American Society of Nephrology and Hypertension (SLANH). He is board certified in Internal Medicine and Nephrology by the American Board of Internal Medicine, and current President of the Mexican Board of Nephrology. He is a former president of the Jalisco College of Nephrology, the Jalisco Medical Society, the National Mexican Association of Nephrologists, and Fellow of the American College of Physicians and the American Society of Nephrology. He is a former councilor of International Society of Nephrology (ISN) and current Chair of the ISN Committee on Kidney Health in Disadvantaged Populations; he's member of the ISN CKD Task Force, the Education Committee, and the Latin American, Dialysis and Ambassadors Program. As director of the Office of Minority Health Research Coordination (OMHRC), Dr. Agodoa led the development of the Institute's Strategic Plan on Minority Health Disparities and he is responsible for monitoring its implementation. The OMHRC addresses diseases and disorders that disproportionately impact the health of minority populations and fosters the recruitment and training of minority biomedical investigators, who are currently in short supply. He also serves as director of the Minority Health Program in the Division of Kidney, Urologic, and Hematologic Diseases. He is the co-project officer of the End-Stage Renal Disease database, part of the United States Renal Data System, which provides national statistics on kidney disease. He oversees the Minority Organ Tissue Donation Program. He has co-authored more than 253 articles in peer-reviewed journals. Dr. Norris is an internationally recognized clinician scientist and health policy leader who has been